Neoplasms, Neuroepithelial clinical trials

The registry lists 26 studies for Neoplasms, Neuroepithelial across more than 10 countries. 5 are recruiting or about to start. 2 of them are mainly about Neoplasms, Neuroepithelial (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 15 narrower conditions too, such as Glioblastoma: 4,245 studies, 953 open.

Get an email when these change. Save the Neoplasms, Neuroepithelial studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 7
Terminated: 6
Recruiting: 4
Status unknown: 4
Active, not recruiting: 2
Withdrawn: 1

Phase

Phase 1: 12
Phase 2: 7
Phase 3: 2
Early Phase 1: 1

Where

United States: 20
Canada: 3
Germany: 2
Italy: 1
Israel: 1
Brazil: 1

Who runs them

DNAtrix, Inc. (2) · Pediatric Brain Tumor Consortium (2) · St. Jude Children's Research Hospital (2) · Children's Oncology Group (1) · Sue O'Dorisio (1) · Montefiore Medical Center (1) · Sociedad de Lucha Contra el Cáncer del Ecuador (1) · Ludwig-Maximilians - University of Munich (1)

What is being tested here

Drugs under test in Neoplasms, Neuroepithelial studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Mirdametinib	1	0	1
G 207	1	0	1
Oncolytic HSV-1 G207	1	0	1
Valproic Acid	0	1	2
ONC206	0	0	1
CLR1404	0	0	1
Gemcitabine	0	0	1
Ribociclib	0	0	1
Sonidegib	0	0	1
Trametinib	0	0	1

Coming up

0phase 3 studies under way

2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Mar 2027Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms · Jazz Pharmaceuticals
Jun 2027Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas · Cellectar Biosciences, Inc.

Who these studies take

Of the 4 Neoplasms, Neuroepithelial studies recruiting now, 0 (0%) set no upper age limit and 4 (100%) stop at 75 or younger. 4 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 4
Age	Women	Men
10	4 (100%)	4 (100%)
18	4 (100%)	4 (100%)
30	2 (50%)	2 (50%)
40	2 (50%)	2 (50%)
50	0 (0%)	0 (0%)
65	0 (0%)	0 (0%)
75	0 (0%)	0 (0%)
85	0 (0%)	0 (0%)

Across all 26 studies, recruiting or not: 77% stop at 75 or younger and 62% at 65; 77% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 26 of 26. search them.